A Rutgers public health expert is available to discuss Pfizer’s vaccine, which has shown to be effective according to recent clinical results, and the steps we can take to increase public trust when a COVID-19 vaccine is finally approved.
“The news of Pfizer’s vaccine effectiveness is auspicious and our next step should be to ensure that people feel safe and secure in receiving the vaccine by developing behavioral programming to ensure that individuals complete both needed doses,” said Perry N. Halkitis, dean of the Rutgers School of Public Health. “Much of this will depend on scholars and scientists working with communities and populations to bring the vaccine to them in a manner that is safe, effective and accessible.”
Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick, and collaborating university-wide, RBHS includes eight schools, a behavioral health network and four centers and institutes. RBHS offers an outstanding education in medicine, dentistry, pharmacy, public health, nursing, biomedical research and the full spectrum of allied health careers. RBHS clinical and academic facilities are located throughout the state.
ABOUT RUTGERS SCHOOL OF PUBLIC HEALTH
The Rutgers School of Public Health - New Jersey’s leading academic institution in public health - is committed to advancing health and wellbeing and preventing disease throughout New Jersey, the United States, and the world, by preparing students as public health leaders, scholars, and practitioners; conducting public health research and scholarship; engaging collaboratively with communities and populations; and actively advocating for policies, programs, and services through the lens of equity and social justice. Learn how the Rutgers School of Public Health is "keeping the ‘public’ in public health,” by visiting them at https://sph.rutgers.edu.